Sener B, Ozdamar A, Aras C, Yanyali A
Istanbul University Eye Research Center, Turkey.
J Refract Surg. 1997 Nov-Dec;13(7):620-3. doi: 10.3928/1081-597X-19971101-08.
To study the safety, efficacy, predictability, and stability of photorefractive keratectomy (PRK) for hyperopia and aphakia.
Fifteen eyes of 15 patients (mean age, 33 +/- 5.95 yrs) were enrolled in the study and divided into three groups. The first group was comprised of six eyes that had hyperopia ranging from +1.75 to +4.75 D; the second group had seven hyperopic eyes ranging from +5.00 to +9.75 D; the third group included two eyes of two aphakic patients. All eyes had PRK with a 193 nm argon fluoride excimer laser (Chiron-Technolas, Keracor 116) with a 10 Hz repetition rate and a fluence of 120 mJ/cm2. The total follow-up time in all eyes was 12 months.
In the lower hyperopia group, 0% eyes were within +/- 0.50 D and 66% (N = 4) of eyes were within +/- 1.00 D of emmetropia with the other two eyes between +1.00 and +2.00 D at 1 year after PRK. In the higher hyperopia group, all eyes had at least +3.00 D of hyperopia at 1 year. In the aphakic group, both eyes achieved less than 50% of the target correction of +10.00 D at 1 year. Final uncorrected visual acuity ranged from 20/20 to 20/30 in the lower hyperopia group, 20/30 to 20/50 in the higher hyperopia group, and count fingers in the aphakic group.
PRK is a relatively safe, stable, and effective procedure with reasonably good predictability for eyes with less than +5.00 D of baseline hyperopia, and poor predictability for eyes with more than +5.00 D of baseline hyperopia. PRK is ineffective in the correction of aphakia.
研究准分子激光原位角膜磨镶术(PRK)治疗远视和无晶状体眼的安全性、有效性、可预测性和稳定性。
15例患者(平均年龄33±5.95岁)的15只眼纳入本研究,分为三组。第一组6只眼,远视度数为+1.75至+4.75 D;第二组7只远视眼,度数为+5.00至+9.75 D;第三组包括2例无晶状体患者的2只眼。所有眼睛均使用波长193 nm的氟化氩准分子激光(Chiron-Technolas,Keracor 116)进行PRK治疗,重复频率为10 Hz,能量密度为120 mJ/cm2。所有眼睛的总随访时间为12个月。
在低度远视组,PRK术后1年时,0%的眼睛屈光不正度数在±0.50 D以内,66%(N = 4)的眼睛屈光不正度数在正视眼的±1.00 D以内,另外两只眼睛的度数在+1.00至+2.00 D之间。在高度远视组,PRK术后1年时所有眼睛的远视度数至少为+3.00 D。在无晶状体组,PRK术后1年时两只眼睛的矫正度数均未达到目标矫正度数+10.00 D的50%。低度远视组最终的裸眼视力范围为20/20至20/30,高度远视组为20/30至20/50,无晶状体组为手动。
对于基线远视度数小于+5.00 D的眼睛,PRK是一种相对安全、稳定且有效的手术,具有较好的可预测性;对于基线远视度数大于+5.00 D的眼睛,PRK的可预测性较差。PRK矫正无晶状体眼无效。